Literature DB >> 10708050

Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones.

D Fenoglio1, G Li Pira, L Lozzi, L Bracci, D Saverino, P Terranova, L Bottone, S Lantero, A Megiovanni, A Merlo, F Manca.   

Abstract

Neutralizing antibodies and specific cytotoxic T lymphocytes (CTL) may contribute to controlling viral spread, and ideally, to virus clearance in HIV infection. Both effector mechanisms depend on specific CD4 T-helper (Th) cells. Nevertheless, HIV hypervariability facilitates appearance of escape mutants for antibodies and for CTL responses. Here we also show that natural mutations (i.e., from sequences of different HIV strains) in an immunodominant Th epitope recognized by human CD4 clones specific for the envelope glycoprotein gp120 escape CD4 T-cell recognition. Furthermore, several natural analogue peptides exert an antagonistic function by inhibiting proliferative response of T cells specific to gp120 with a wild-type sequence. If similar events occur in vivo, they may represent an additional escape mechanism for HIV. In fact, antagonism for CD4 Th response may occur during superinfection with a different strain, or with the appearance of a variant carrying a mutated antagonistic sequence. In both cases, impaired Th cell function could lead to reduced immune control of HIV infection by interfering with CTL and antibody response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708050     DOI: 10.1097/00126334-200001010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.

Authors:  Philip J Norris; Howell F Moffett; Christian Brander; Todd M Allen; Kristin M O'Sullivan; Lisa A Cosimi; Daniel E Kaufmann; Bruce D Walker; Eric S Rosenberg
Journal:  AIDS Res Hum Retroviruses       Date:  2004-03       Impact factor: 2.205

2.  Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.

Authors:  Cheryl L Day; Georg M Lauer; Gregory K Robbins; Barbara McGovern; Alysse G Wurcel; Rajesh T Gandhi; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.

Authors:  Howard A Ross; Allen G Rodrigo
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.

Authors:  Shuping Wang; Rico Buchli; Jennifer Schiller; Jianen Gao; Rodney S VanGundy; William H Hildebrand; David D Eckels
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

5.  Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.

Authors:  Peter C Chien; Sandra Cohen; Michael Tuen; James Arthos; Pei-de Chen; Sukeshi Patel; Catarina E Hioe
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Authors:  Liljana Stevceva; Victor Yoon; Angela Carville; Beatriz Pacheco; Michael Santosuosso; Birgit Korioth-Schmitz; Keith Mansfield; Mark C Poznansky
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

7.  An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope.

Authors:  Art F Y Poon; Fraser I Lewis; Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  PLoS Comput Biol       Date:  2007-10-11       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.